Donanemab
Drug / Medication
A drug that removes amyloid beta from the brain, potentially part of a cocktail therapy for Alzheimer's disease alongside Klotho.
Mentioned in 2 videos
Videos Mentioning Donanemab

164 - Diagnosing, preventing, & treating Alzheimer’s disease, & life lessons from dementia patients
Peter Attia MD
A Lilly study drug, an anti-amyloid monoclonal antibody, that recently showed it met primary and secondary endpoints at the ADPD meeting, offering another promising development in Alzheimer's treatment.

303-A breakthrough in Alzheimer’s disease: potential of klotho for brain health & as a therapeutic
Peter Attia MD
A drug that removes amyloid beta from the brain, potentially part of a cocktail therapy for Alzheimer's disease alongside Klotho.